Contact Us

The Visualase™ system

Learn more about the Visualase™ system from Medtronic

 

See details

Surgical synergy
 

Discover streamlined workflows, robotically assisted placement, realtime imaging, and more

See details

MRI
 

Learn more about MRI guided laser ablation using the Visualase™ system
 

See details

Indications
 

Learn more about indications and patient selection for treatment using the Visualase™ system

See details

The Visualase™ system puts faster recovery within reach

The Visualase™ system is a minimally-invasive surgical option that is able to cure epilepsy and brain tumour patients.1 With higher patient satisfaction and faster recovery times2-4, your patients can get back to getting better.

Discover the Visualase™ system
lady-with-clipboard.png
happy man

Tumour removal

With unmatched surgical precision,5-7 the Visualase™ system is ideal for operating on deep-seated and hard-to-reach brain lesions. Change what is possible for your brain tumour patients.

Learn more about the Visualase™ system for brain tumours

Epilepsy

The Visualase™ system can deliver new outcomes8-12 for patients with drug-resistant epilepsy, by permanently ablating epileptic foci in a minimally-invasive procedure.

Learn more about the Visualase™ system for epilepsy
patient-doctor-with-clipboard
woman-looking-screen

Surgical synergy™ for the Visualase™ system-integrated solutions from planning to surgery

Discover how Medtronic can help streamline procedural planning, catheter placement, laser trajectory, and thermal ablation using an integrated suite of tools and technologies.

Learn more

Medical education for the Visualase™ system

Access on-demand procedural videos, webinars, and more at Medtronic Academy.
Visit Medtronic Academy

Video: Visualase™ and Stealth Autoguide™ workflow animation - (03:39)

Video showing full Visualase™ procedural workflow using Stealth Autoguide™ robotic system as the stereotactic method for catheter placement
More information (see more) Less information (see less)

MRI guidelines &Manuals

The Visualase™ system

Checklist: Visualase Implementation Program 

Agenda: Visualase Implementation Program 

Technical Checklist: Visualase Implementation Program 

Better support

We can help you find a treatment option that is right for your patient. Our team is here to support you with the information you need to make the most informed decisions for your patient’s care.

Sign up to be contacted by a Medtronic representative for more customised support, to be notified of educational opportunities, and to hear about our latest product innovations.

Contact us

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content. For more information, see the Medtronic privacy notice.

You can always change your preferences or update your personal details by visiting the Preference center.

See the Preference center

Brief statement:
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.
  1. Visualase™ MRI-Guided Laser Ablation System Manual (9735542, V3). Published September 2019.
  2. Kang et al, 2016, Epilepsia, 57(2):325-334. doi:10.1111/epi.13284
  3. Waseem et al, 2015, Epilepsy & Behavior, 51:152-157. doi:10.1016/j.yebeh.2015.07.022
  4. Leuthardt et al, 2017, PharmacoEconomics Open. 1(1):53-63. doi:10.1007/s41669-016-0003-2
  5. Yuen J, Zhu CXL, Chan DTM, et al. Stereotact Funct Neurosurg. 2014;92(3):160-169. doi:10.1159/000360862.
  6. Hawasli AH, Ray WZ, Murphy RKJ, Dacey RG, Leuthardt EC. Operative Neurosurgery. 2012;70:onsE332-onsE338. doi:10.1227/NEU.0b013e318232fc90.
  7. Mohammadi AM, Schroeder JL. Expert Review of Medical Devices. 2014;11(2):109-119. doi:10.1586/17434440.2014.882225.
  8. Drane DL. Epilepsy Research. 2018;142:170-175. doi:10.1016/j.eplepsyres.2017.09.016.
  9. Drane DL, Loring DW, Voets NL, et al.  Epilepsia. 2015;56(1):101-113. doi:10.1111/epi.12860.
  10. Youngerman BE, Save AV, McKhann GM.  Neurosurg. 2020;86(4):E366-E382. doi:10.1093/neuros/nyz556.
  11. Donos C, Breier J, Friedman E, et al.  Epilepsia. 2018;59(7):1421-1432. doi:10.1111/epi.14443. 
  12. Gross RE, Stern MA, Willie JT, et al.  Ann Neurol. 2018;83(3):575-587. doi:10.1002/ana.25180.